Rubicon Research Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Rubicon Research Ltd. authored by Hem Securities and published by - Trendlyne research reports.
Item: Rubicon Research Ltd.
Rating: 5
Author: Hem Securities

Keep track of all breaking news and updates on Rubicon Research Ltd. from all sources in a single place.

Rubicon Research Ltd.

09 Oct 2025

Rubicon Research IPO opens: Check price band, GMP, reviews, key dates here

Business Standard

As the issue opens for subscription today, here are the key details of Rubicon Research IPO that investors should be aware of before subscribing to Rubicon Research IPO

ICICI Direct released a IPO Note report for Rubicon Research Ltd. on 09 Oct, 2025.

Can Rubicon Research sustain its impressive growth while facing US market risks?

Economic Times | 09 Oct 2025

Rubicon Research Ltd.

09 Oct 2025

RUBICON RESEARCH INDIA LIMITED

IPO Subscribe: Rubicon Research Ltd.

Hem Securities

Company is a pharmaceutical formulations company, driven by innovation through focused research and development, with an increasing portfolio of specialty products and drug-device combination products targeting regulated markets and in particular the United States. Based on the peer set (of seven listed Indian companies assessed by F&S, and Company), company is the only Indian pharmaceutical player with a complete focus on regulated markets. Between Fiscals 2023 and 2025, company was...

ICICI Direct released a IPO Note report for Rubicon Research Ltd. on 09 Oct, 2025.

Rubicon Research Ltd.

09 Oct 2025

Rubicon Research : IPO

IPO Note: Rubicon Research Ltd.

ICICI Direct

Rubicon is one of the fastest growing Indian pharmaceutical companies focusing completely on the US market which contributed ~99% of the FY25 revenues. It has a pipeline of 17 products under review with the USFDA and...

ICICI Direct released a IPO Note report for Rubicon Research Ltd. on 09 Oct, 2025.

Rubicon Research Ltd.

08 Oct 2025